Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Cynthia Epperson to Premenstrual Syndrome

This is a "connection" page, showing publications Cynthia Epperson has written about Premenstrual Syndrome.

 
Connection Strength
 
 
 
5.192
 
  1. Hantsoo L, Grillon C, Sammel M, Johnson R, Marks J, Epperson CN. Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder. Psychopharmacology (Berl). 2021 Oct; 238(10):2985-2997.
    View in: PubMed
    Score: 0.743
  2. Epperson CN, Hantsoo LV. Making Strides to Simplify Diagnosis of Premenstrual Dysphoric Disorder. Am J Psychiatry. 2017 01 01; 174(1):6-7.
    View in: PubMed
    Score: 0.542
  3. Hantsoo L, Epperson CN. Premenstrual Dysphoric Disorder: Epidemiology and Treatment. Curr Psychiatry Rep. 2015 Nov; 17(11):87.
    View in: PubMed
    Score: 0.500
  4. Hantsoo L, Czarkowski KA, Child J, Howes C, Epperson CN. Selective serotonin reuptake inhibitors and endothelial function in women. J Womens Health (Larchmt). 2014 Jul; 23(7):613-8.
    View in: PubMed
    Score: 0.453
  5. Epperson CN. Premenstrual dysphoric disorder and the brain. Am J Psychiatry. 2013 Mar; 170(3):248-52.
    View in: PubMed
    Score: 0.416
  6. Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry. 2012 May; 169(5):465-75.
    View in: PubMed
    Score: 0.392
  7. Kim DR, Czarkowski KA, Epperson CN. The relationship between bipolar disorder, seasonality, and premenstrual symptoms. Curr Psychiatry Rep. 2011 Dec; 13(6):500-3.
    View in: PubMed
    Score: 0.381
  8. Guille C, Spencer S, Cavus I, Epperson CN. The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment. Epilepsy Behav. 2008 Jul; 13(1):12-24.
    View in: PubMed
    Score: 0.295
  9. Epperson CN, Pittman B, Czarkowski KA, Stiklus S, Krystal JH, Grillon C. Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology. 2007 Oct; 32(10):2190-8.
    View in: PubMed
    Score: 0.274
  10. Miller KN, Standeven L, Morrow AL, Payne JL, Epperson CN, Hantsoo L. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder. Psychoneuroendocrinology. 2024 Feb; 160:106684.
    View in: PubMed
    Score: 0.219
  11. Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W, Weiss E, Rothman DL, Krystal JH. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry. 2002 Sep; 59(9):851-8.
    View in: PubMed
    Score: 0.201
  12. Dubol M, Wikstr?m J, Lanzenberger R, Epperson CN, Sundstr?m-Poromaa I, Comasco E. Grey matter correlates of affective and somatic symptoms of premenstrual dysphoric disorder. Sci Rep. 2022 04 09; 12(1):5996.
    View in: PubMed
    Score: 0.195
  13. Wikman A, Sacher J, Bixo M, Hirschberg AL, Kopp Kallner H, Epperson CN, Comasco E, Sundstr?m Poromaa I. Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder. BMC Womens Health. 2022 02 11; 22(1):35.
    View in: PubMed
    Score: 0.193
  14. Ismaili E, Walsh S, O'Brien PMS, B?ckstr?m T, Brown C, Dennerstein L, Eriksson E, Freeman EW, Ismail KMK, Panay N, Pearlstein T, Rapkin A, Steiner M, Studd J, Sundstr?m-Paromma I, Endicott J, Epperson CN, Halbreich U, Reid R, Rubinow D, Schmidt P, Yonkers K. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016 12; 19(6):953-958.
    View in: PubMed
    Score: 0.131
  15. Nevatte T, O'Brien PM, B?ckstr?m T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman EW, Halbreich U, Ismail K, Panay N, Pearlstein T, Rapkin A, Reid R, Rubinow D, Schmidt P, Steiner M, Studd J, Sundstr?m-Poromaa I, Yonkers K. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health. 2013 Aug; 16(4):279-91.
    View in: PubMed
    Score: 0.105
  16. Forray A, Focseneanu M, Pittman B, McDougle CJ, Epperson CN. Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period. J Clin Psychiatry. 2010 Aug; 71(8):1061-8.
    View in: PubMed
    Score: 0.086
  17. Amin Z, Mason GF, Cavus I, Krystal JH, Rothman DL, Epperson CN. The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women. Pharmacol Biochem Behav. 2006 Aug; 84(4):635-43.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)